Duowell® vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With Hypertension

Inclusion Criteria (All of the followings) * 40 to 75 years old diagnosed with hypertension * at screening, SBP ≥ 140 mmHg * at randomization, 130 mmHg ≤ SBP ≤160 mmHg or 80 mmHg ≤ DBP ≤ 100 mmHg * at screening, ASCVD risk ≥ 5 % * Those who did not take the dyslipidemic medications during screening or who stopped medication for more than 2 months * at screening, 130 mg/dL ≤ Calculated (or Measured) Serum LDL-C ≤ 190 mg/dL * Pregnancy test negative and and who has agreed to perform effective contraception during the clinical trial Exclusion Criteria (Any of the followings) * known hypersensitivity to AT-1 receptor blockers or statins * Those who are treated with secondary hypertension during screening * Those who are being treated for malignant hypertension during screening * Those who are taking concurrent medication that may affect blood pressure during screening * Those who have been diagnosed with myocardial infarction or unstable angina or stroke within the last 6 months at screening * Patients with heart failure NYHA III-IV or Left Ventricular Ejection Fraction \<40% within the last 6 months at screening * Patients with valve disease with hemodynamically significant (over moderate degree) obstructive * Those with known atrial fibrillation or atrioventricular conduction disturbance * Those who show the following numerical values during the screening test 1. CPK ≥ 3 times the normal upper limit 2. Serum Creatinine \> 3 mg/dL 3. Serum Potassium \> 5.5 mmol/L 4. ALT or AST ≥ 3 times the upper normal limit * Those with known bilateral renal artery stenosis * Patients who underwent open heart surgery within 4 weeks prior to randomization and who had a cardiac surgery plan * Those taking statins within 8 weeks before randomization * Those with severe obstructive, limited or other pulmonary disease history * Those with non-cardiac disease that can significantly shorten the expected life span to less than 2 years (eg, severe cancer) * at screening, Anti-HIV Ab, HBsAg, HCV Ab positive